Heartflow, Inc. Common Stock
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- John Farquhar
- Full Time Employees
- 843
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 331 E. Evelyn Avenue Mountain View CA United States of America 94041
- IPO Date
- Aug 7, 2025
- CIK
- 0001464521
- Website
- heartflow.com
- Similar Companies
- Business
- HeartFlow, Inc. is a medical technology firm that delivers advanced non-invasive solutions globally for the assessment and management of coronary artery disease. Through its HeartFlow Platform, the company leverages artificial intelligence and computational fluid dynamics to construct a unique three-dimensional cardiac model from a routine coronary computed tomography angiography, a specialized imaging technique that yields detailed visuals of the heart's vessels. This advanced platform offers critical insights into coronary blood flow, the degree of arterial narrowing (stenosis), and the characteristics of plaque, thereby enhancing diagnostic capabilities beyond conventional non-invasive assessments. These capabilities help clinicians identify the significance of blockages and avoid unnecessary invasive procedures. Established in 2007, the company maintains its headquarters in Mountain View, California.
What Does the HeartFlow CEO's Sale of Over 20,000 Company Shares Mean for Investors?
HeartFlow: A Premium AI Diagnostics Story
New Data at SCCT 2026 Reinforce Heartflow Plaque Analysis as the Standard for AI-Powered Coronary Artery Disease Management
Heartflow vs. Omeros: Which Healthcare Innovator Stock Is a Better Buy in 2026?
Heartflow vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?
HeartFlow vs. NovoCure: Which Emerging Healthcare Stock Is a Better Buy in 2026?
Baron Discovery Fund Q1 2026: Who Moved The Needle
Is HeartFlow Stock a Buy After an Institutional Investor Initiated a Position Worth $2.7 Million?
Heartflow Q1 Earnings Call Highlights
HeartFlow, Inc. (HTFL) Q1 2026 Earnings Call Transcript
Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
Wall Street Waits for the SpaceX IPO, These 2 Under-the-Radar IPOs Could Already Be Making You Money
Stanford Trustees Exited HeartFlow Stock for $8.5 Million. Here's What That Means for Investors.
Heartflow to Report First Quarter 2026 Financial Results on May 14, 2026
Heartflow, Inc. (NASDAQ:HTFL) Given Average Rating of “Moderate Buy” by Analysts
Heartflow Files Patent Infringement Lawsuit Against Cleerly
Campbell Rogers Sells 64,533 Shares of Heartflow (NASDAQ:HTFL) Stock
How Decentralized AI is Unlocking Value in Cardiac Diagnostics
What Investors Should Know About One HeartFlow Insider's $2 Million Stock Sale
Is HeartFlow Stock a Buy After Capricorn Investment Group Bought 1.7 Million Shares?